Cue Biopharma (CUE) Debt Ratio (2022 - 2025)
Historic Debt Ratio for Cue Biopharma (CUE) over the last 4 years, with Q3 2025 value amounting to 0.05.
- Cue Biopharma's Debt Ratio fell 5619.98% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year decrease of 5619.98%. This contributed to the annual value of 0.13 for FY2024, which is 143.43% up from last year.
- Cue Biopharma's Debt Ratio amounted to 0.05 in Q3 2025, which was down 5619.98% from 0.06 recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Debt Ratio ranged from a high of 0.15 in Q1 2025 and a low of 0.05 during Q3 2025
- Moreover, its 4-year median value for Debt Ratio was 0.13 (2022), whereas its average is 0.12.
- As far as peak fluctuations go, Cue Biopharma's Debt Ratio surged by 2115.63% in 2023, and later plummeted by 5689.09% in 2025.
- Over the past 4 years, Cue Biopharma's Debt Ratio (Quarter) stood at 0.11 in 2022, then grew by 21.16% to 0.13 in 2023, then grew by 1.43% to 0.13 in 2024, then crashed by 61.31% to 0.05 in 2025.
- Its Debt Ratio stands at 0.05 for Q3 2025, versus 0.06 for Q2 2025 and 0.15 for Q1 2025.